Joanne Holland

Corvus Capital, Inc. provides investment and asset management services. Its services include corporate development, investment accounting, corporate legal counseling, and equity capital market research services. The company is headquartered in Road Town, British Virgin Islands.

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

Nokia (UK) Ltd. distributes mobile phones and fixed telecom networks. It provides wireless data and mobile communications, information technology, and media services. The firm also provides mobile games, multimedia, and enterprise solutions to customers. The company was founded in 1990 and is headquartered in Huntingdon, the United Kingdom.

Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001.

GSK Pharmaceutical Trading SA engages in manufacture of pharmaceutical products. The company was founded in 1994 and is headquartered in Brasov, Romania.

Corvus Capital Ltd. operates as an investment and South African management company. The private company is based in Johannesburg, South Africa and has subsidiaries in the UK and the Cayman Islands. The company was founded by Andrew Regan, who has been the CEO since incorporation.

Millenium Group Ltd. provides marketing and communication services. The private company is based in Shipley, UK. and has subsidiaries in United Kingdom.

Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom.

McCann Erickson (Germany) provides brand communication and public relation services. The private company is based in Frankfurt, Germany.

RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.

Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom.

Advent Pharmaceuticals Pty Ltd. designs and develops dry powder inhaler devices. The firm focuses on the development of dry powder inhalation platforms for the treatment of asthma and chronic obstructive pulmonary diseases. The company was founded by Henry Kenneth Windle in 2001 and is headquartered in Melbourne, Australia.

Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom.

Serco, Inc. provides services and project management support services. It specializes in fleet management, transportation, information technology and business consulting, engineering, human resources, and logistics services. The firm also offers human capital management, systems integration, lifecycle management, and economic cost analysis solutions. The company was founded in 1988 and is headquartered in Reston, VA.

Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Intelligent OMICS Ltd. provides analytical and bioinformatics services. Its bioinformatics algorithms are able to identify patients who respond to a particular therapy in new clinical trials or in previous, failed trails. The firm helps drug development companies create new drugs applicable to specific patient sub-groups. The company was founded by Graham Ball and Robert Rees in 2009 and is headquartered in Nottingham, the United Kingdom.

Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom.

Part of N1 Singer Ltd., Singer Capital Markets Securities Ltd. is a brokerage firm. The company is based in London, UK. The British company was founded in 2012 by Timothy Bruce Cockroft, Peter Welch. Timothy Bruce Cockroft has been the CEO since 2012.

Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom.

Genesis Technical Systems (UK) Ltd. provides broadband technologies and internet for mobile telecom operators. It solutions include copper backhaul, the last mile, rural broadband and small cell backhaul. The firm products include mBond and DSL Rings. The company was founded by Stephen Peter Cooke in 2007 and is headquartered in Coventry, the United Kingdom.

Medeor LLP provides economic services. The private company is based in Cambridge, UK. and has subsidiaries in United Kingdom. Medeor was founded in 2008.

Medeor Pharma Ltd. provides management consulting services.

Novai Ltd. operates as a biotechnology company. It offers gene therapies, clinical research, optimize drug development services. The company was founded by Maria Francesca Cordeiro on February 12, 2020 and is headquartered in Reading, the United Kingdom.

Part of Arecor Therapeutics Plc, Tetris Pharma Ltd. is a British company that sells and distributes pharmaceutical products. The company is based in Marlow, UK. The CEO of the company is Shafiq Choudhary. Tetris Pharma was acquired by Arecor Therapeutics Plc on August 04, 2022 for $7.33 million.

Sigma Aldrich Co. Ltd. engages in the science and technology company. Its products include analytical standards, gas chromatography, spectroscopy, acids and bases, catalysis and inorganics, organometallics, solvents, antibodies, biochemical and reagents, cell biology, microbiology, and polymer sciences. It also offers basic research, product and process development, manufacturing and production, and regulatory compliance services. The company was founded on December 10, 1987 and is headquartered in Gillingham, the United Kingdom.